Related references
Note: Only part of the references are listed.TGFβ biology in cancer progression and immunotherapy
Rik Derynck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Inference and analysis of cell-cell communication using CellChat
Suoqin Jin et al.
NATURE COMMUNICATIONS (2021)
A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma
Lei-Ming Wang et al.
CHINESE MEDICAL JOURNAL (2021)
STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway
Rui Zhang et al.
CANCER SCIENCE (2020)
Dedifferentiated Chordoma Clinicopathologic and Molecular Characteristics With Integrative Analysis
Yin P. Hung et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology
Ye Wang et al.
FRONTIERS IN ONCOLOGY (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Ashley Maynard et al.
CELL (2020)
Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
Ilseon Hwang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering
Arshi Arora et al.
GENOME MEDICINE (2020)
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
Lucia Cottone et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)
Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis
Xiu-wu Pan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor
Ming-Xiang Zou et al.
NEUROSURGERY (2019)
CellMarker: a manually curated resource of cell markers in human and mouse
Xinxin Zhang et al.
NUCLEIC ACIDS RESEARCH (2019)
Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review
Tong Meng et al.
FRONTIERS IN ONCOLOGY (2019)
Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy
Romy M. Heilmann et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance
Emre Can Tuysuz et al.
EXPERIMENTAL CELL RESEARCH (2019)
Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma
Yukina Morimoto et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Application of nomograms to predict overall and cancer-specific survival in patients with chordoma
Zheng Weipeng et al.
JOURNAL OF BONE ONCOLOGY (2019)
Advances in immune checkpoint inhibitors for bone sarcoma therapy
Pichaya Thanindratarn et al.
JOURNAL OF BONE ONCOLOGY (2019)
The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma
Ming-Xiang Zou et al.
NEUROSURGERY (2019)
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Dvir Aran et al.
NATURE IMMUNOLOGY (2019)
Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling (vol 11, pg 1425, 2013)
H. E. Barker et al.
MOLECULAR CANCER RESEARCH (2019)
PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer
Seema Parte et al.
STEM CELL REVIEWS AND REPORTS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TCRαβ+CD3+CD4-CD8- (double negative) T cells in autoimmunity
D. Brandt et al.
AUTOIMMUNITY REVIEWS (2018)
TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators
Julian Nuechel et al.
AUTOPHAGY (2018)
Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression
Shengquan Huang et al.
CANCER SCIENCE (2018)
A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
Ralph Stadhouders et al.
JOURNAL OF AUTOIMMUNITY (2018)
Single-cell RNA sequencing for the study of development, physiology and disease
S. Steven Potter
NATURE REVIEWS NEPHROLOGY (2018)
TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition
Anassuya Ramachandran et al.
ELIFE (2018)
Clinicopathologic implications of CD8(+)/Foxp3(+) ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients
Ming-Xiang Zou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients
Sayaka Obayashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
Ying Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
The driver landscape of sporadic chordoma
Patrick S. Tarpey et al.
NATURE COMMUNICATIONS (2017)
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
Sidharth V. Puram et al.
CELL (2017)
Distributing signaling proteins in space and time: the province of cytonemes
Thomas B. Kornberg
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
The molecular aspects of chordoma
Sukru Gulluoglu et al.
NEUROSURGICAL REVIEW (2016)
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
E. Bompas et al.
ANNALS OF ONCOLOGY (2015)
Building a global consensus approach to chordoma: a position paper from the medical and patient community
Silvia Stacchiotti et al.
LANCET ONCOLOGY (2015)
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Involvement of Ubiquitin-Conjugating Enzyme E2C in Proliferation and Invasion of Prostate Carcinoma Cells
Song Shuliang et al.
ONCOLOGY RESEARCH (2013)
Chordoma: current concepts, management, and future directions
Brian P. Walcott et al.
LANCET ONCOLOGY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links
Christina Scheel et al.
SEMINARS IN CANCER BIOLOGY (2012)
Share Paper
